Journal articles
Carr A; Mammucari R; Foster NR, 2010, 'Particle formation of budesonide from alcohol-modified subcritical water solutions', International Journal of Pharmaceutics, 405, pp. 169 - 180, http://dx.doi.org/10.1016/j.ijpharm.2010.11.042
Samaras K; Richardson R; Carr AD, 2010, 'Postprandial lipid effects of low-dose ritonavir vs. raltegravir in HIV-uninfected adults', AIDS, 24, pp. 1727 - 1731
Carr A; Mammucari R; Foster NR, 2010, 'Solubility and Micronization of Griseofulvin in Subcritical Water', Industrial and Engineering Chemistry Research, 49, pp. 3403 - 3410, http://dx.doi.org/10.1021/ie901189r
Carr A; Branch A; Mammucari R; Foster NR, 2010, 'The solubility and solubility modelling of budesonide in pure and modified subcritical water solutions', Journal of Supercritical Fluids, 55, pp. 37 - 42, http://dx.doi.org/10.1016/j.supflu.2010.08.001
O'Connor MB; O'Connor C; Saunders JA; Sheehan C; Murphy E; Horgan M; Carr A; Cooper DA, 2009, 'HIV positive: Who do they tell?', International Journal of STD and AIDS, 20, pp. 517 - 518, http://dx.doi.org/10.1258/ijsa.2009.009146
Calmy A; Gayet-Ageron A; Montecucco F; Nguyen A; Mach F; Burger F; Ubolyam S; Carr A; Ruxungtham K; Hirschel B; Ananworanich J, 2009, 'HIV increases markers of cardiovascular risk: Results from a randomized, treatment interruption trial', AIDS, 23, pp. 929 - 939, http://dx.doi.org/10.1097/QAD.0b013e32832995fa
Mitsuyasu RT; Merigan TC; Carr A; Zack JA; Winters MA; Workman C; Bloch M; Lalezari J; Becker S; Thornton L; Akil B; Khanlou H; Finlayson R; McFarlane R; Smith DE; Garsia R; Ma D; Law M; Murray JM; Von Kalle C; Ely JA; Patino SM; Knop AE; Wong P; Todd AV; Haughton M; Fuery C; Macpherson JL; Symonds GP; Evans LA; Pond SM; Cooper DA, 2009, 'Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34 + cells', Nature Medicine, 15, pp. 285 - 292, http://dx.doi.org/10.1038/nm.1932
Calmy A; Hirschel B; Cooper DA; Carr AD, 2009, 'A new era of antiretroviral drug toxicity', Antiviral Therapy, 14, pp. 165 - 179
Grund B; Peng G; Gibert C; Hoy JF; Isaksson R; Shlay J; Martinez E; Reiss P; Visnegarwala F; Carr AD, 2009, 'Continuous antiretroviral therapy decreases bone mineral density', AIDS, 23, pp. 1519 - 1529
Samaras K; Wand HC; Law MG; Emery S; Cooper DA; Carr AD, 2009, 'Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition, visceral fat, lipid, glucose and adipokine metabolism', Current HIV Research, 7, pp. 454 - 461
Carr AD; Amin J, 2009, 'Efficacy and tolerability of initial antiretroviral therapy: A systematic review', AIDS, 23, pp. 343 - 353
Calmy A; Fux C; Norris R; Vallier N; Delhumeau C; Samaras K; Hesse K; Hirschel B; Cooper DA; Carr AD; Hesse , 2009, 'Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study', Journal of Infectious Diseases, 200, pp. 1746 - 1754, http://dx.doi.org/10.1086/644785
Carey DL; Baker D; Petoumenos K; Chuah J; Rogers G; Watson J; Cooper DA; Emery S; Carr AD, 2009, 'Poly-L-lactic acid for HIV-1 facial lipoatrophy: 48-week follow-up', HIV Medicine, 10, pp. 163 - 172
Samaras K; Gan SK; Peake PW; Carr AD; Campbell LV, 2009, 'Proinflammatory markers, insulin sensitivity, and cardiometabolic risk factors in treated HIV infection', Obesity, 17, pp. 53 - 59
Martin A; Bloch MT; Amin J; Baker DL; Cooper DA; Emery S; Carr AD, 2009, 'Simplification of Antiretroviral Therapy with Tenofovir-Emtricitabine or Abacavir-Lamivudine: A Randomized, 96-Week Trial', Clinical Infectious Diseases, 49, pp. 1591 - 1601
Emery S; Neuhaus JA; Phillips AN; Babiker A; Cohen CJ; Gatell-Artigas JM; Girard PM; Grund B; Law M; Losso MH; Palfreeman A; Wood R; Gordin F; Finley E; Dietz D; Chesson C; Vjecha M; Standridge B; Schmetter B; Grue L; Willoughby M; Demers A; Lundgren JD; Phillips A; Dragsted UB; Jensen KB; Fau A; Borup L; Pearson M; Jansson PO; Jensen BG; Benfield TL; Darbyshire JH; Babiker AG; Fleck SL; Collaco-Moraes Y; Cordwell B; Dodds W; van Hooff F; Wyzydrag L; Cooper DA; Drummond FM; Connor SA; Satchell CS; Gunn S; Oka S; Delfino MA; Merlin K; McGinley C; Neaton JD; Bartsch G; Duchene A; George M; Harri-Harrison M; Hogan C; Krum E; Larson G; Miller C; Nelson R; Neuhaus J; Roediger MP; Schultz T; Thackeray L; Prineas R; Campbell C; Perez G; Lifson A; Duprez D; Hoy J; Lahart C; Perlman D; Price R; Rhame F; Sampson J; Worley J; Rein BM; Dersimonian R; Brody BA; Daar ES; Dubler NN; Fleming TR; Freeman DJ; Kahn JP; Kim KM; Medoff G; Modlin JF; Moellering R; Murray BE; Pick B; Robb ML; Scharfstein DO; Sugarman J; Tsiatis A; Tuazon C; Zoloth L; Klingman K; Lehrman S; Lazovski J; Belloso WH, 2008, 'Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART Study', Journal of Infectious Diseases, 197, pp. 1133 - 1144, http://dx.doi.org/10.1086/586713
Calmy A; Carey D; Mallon PWG; Wand H; Law M; Cooper DA; Carr A; Yeni P; Aboulker JP; Antunes F; Babiker A; Becker M; Boukli N; Brun-Vezinet F; Carey D; Churchill D; Conway B; Chazallon C; Darbyshire J; De Wit S; Dusak B; Emery S; Flepp M; Floridia M; Gatell J; Girard PM; Goodall RL; Hemmer R; Hooker M; Law M; Loveday C; Lundgren J; Manion D; Mulcahy F; Orani A; Pharo C; Ristola M; Salzberger B; Sandstrom E; Schechter M; Schnittman S; Seligmann M; Staszewski S; Stek M; Verbiest W; Weber J; Lee W; Phipps S; Sharkey T; Dimayuga R; Jones M; Jutha S; Kraus D; Zastre B; Dragsted U; Grønholdt A; Ludgren J; Mollerup D; Skinnes L; Kahi S; Léger L; Meiffrédy V; Rodier AS; Saïdi Y; Cruceta A; Lenz B; Rochon J; Schade-Brittinger C; Wittenberg M; Wolf H; Bucciardini R; Fragola V; Galluzzo CM; Germinario E; Guidi M; Innocenti F; Massella M; Mattei A; Mirra M; Paoloni MI; Polizzi C; Pirillo M; Vella S; Gremlich E; Mosimann A; Hudson F; Johnson D; Kelleher P; Poland A; Taylor K; Wait J; Withnall R; Mallon P; Norris R; Rafferty M; Lacey M; Chisholm D; Samaras K, 2008, 'Early changes in adipokine levels and baseline limb fat may predict HIV lipoatrophy over 2 years following initiation of antiretroviral therapy', HIV Medicine, 9, pp. 101 - 110, http://dx.doi.org/10.1111/j.1468-1293.2007.00527.x
Carr A; Grund B; Neuhaus J; El-Sadr WM; Grandits G; Gibert C; Prineas RJ, 2008, 'Asymptomatic myocardial ischaemia in HIV-infected adults', AIDS, 22, pp. 257 - 267, http://dx.doi.org/10.1097/QAD.0b013e3282f20a77
D'Arminio Monforte A; Abrams D; Pradier C; Weber R; Reiss P; Bonnet F; Kirk O; Law M; De Wit S; Friis-Møller N; Phillips AN; Sabin CA; Lundgren JD; Collins S; Loeliger E; Tressler R; Weller I; Worm SW; Sjøl A; Sawitz LA; Rickenbach M; Pezzotti P; Krum E; Gras L; Balestre E; Sundström A; Poll B; Fontas E; Torres F; Petoumenos K; Kjær J; De Wolf F; Zaheri S; Gras Athena L; Bronsveld W; Hillebrand-Haverkort ME; Prins JM; Bos JC; Eeftinck Schattenkerk JKM; Geerlings SE; Godfried MH; Lange JMA; Van Leth FC; Lowe SH; Van Der Meer JTM; Nellen FJB; Pogány K; Van Der Poll T; Ruys TA; Sankatsing ; Steingrover R; Van Twillert G; Van Der Valk M; Van Vonderen MGA; Vrouenraets SME; Van Vugt M; Wit FWMN; Van Eeden A; Ten Veen JH; Van Dam PS; Roos JC; Brinkman K; Frissen PHJ; Weigel HM; Mulder JW; Van Gorp ECM; Meenhorst PL; Mairuhu ATA; Veenstra J; Danner SA; Van Agtmael MA; Claessen FAP; Perenboom RM; Rijkeboer A; Richter C; Van Der Berg J; Van Leusen R; Vriesendorp R; Jeurissen FJF; Kauffmann RH; Koger ELW; Bravenboer B; Ten Napel CHH; Kootstra GJ; Sprenger HG; Miesen WMAJ; Doedens R; Scholvinck EH; Ten Kate RW; Van Houte DPF; Polee M; Kroon FP; Van Den B; Van Dissel JT; Schippers EF; Schreij G; Van De Geest S; Verbon A; Koopmans PP; Keuter M, 2008, 'HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies', AIDS, 22, pp. 2143 - 2153, http://dx.doi.org/10.1097/QAD.0b013e3283112b77
Boyd MA; Truman M; Holes G; Anderson JA; Dwyer DE; Carr AD, 2008, 'A randomized study to evaluate injection site reactions using three different enfuvirtide delivery mechanisms (the OPTIONS study)', Antiviral Therapy, 13, pp. 449 - 453
Mallon PW; Sedwell R; Rogers GJ; Nolan D; Unemori P; Hoy JF; Samaras K; Kelleher AD; Emery S; Cooper DA; Carr AD, 2008, 'Effect of Rosiglitazone on Peroxisome Proliferator-Activated Receptor gamma Gene Expression in Human Adipose Tissue Is Limited by Antiretroviral Drug-Induced Mitochondrial Dysfunction', Journal of Infectious Diseases, 198, pp. 1794 - 1803
Carr AD; Ritzhaupt A; Zhang W; Zajdenverg R; Workman C; Gatell J; Cahn PE; Chaves R, 2008, 'Effects of boosted tipranavir and lopinavir on body composition, insulin sensitivity and adipocytokines in antiretroviral-naive adults', AIDS, 22, pp. 2313 - 2321
Lundgren JD; Babiker AG; El-Sadr W; Emery S; Grund B; Neaton JD; Neuhaus J; Phillips A, 2008, 'Inferior clinical outcome of the CD4(+) cell count guided antiretroviral treatment interruption strategy in the SMART study: Role of CD4(+) cell counts and HIV RNA levels during follow-up', Journal of Infectious Diseases, 197, pp. 1145 - 1155, http://dx.doi.org/10.1086/529523
Phillips AN; Carr AD; Neuhaus J; Visnegarwala F; Prineas R; Burman W; Williams IR; Drummond F; Duprez D; Belloso WH; Goebel F; Grund B; Hatzakis A; Vera J; Lundgren JD, 2008, 'Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial', Antiviral Therapy, 13, pp. 177 - 187
Carr AD, 2008, 'Pathogenesis of cardiovascular disease in HIV infection', Current opinion in HIV & AIDS, 3, pp. 234 - 239
El-Sadr W; Grund B; Neuhaus J; Babiker AG; Cohen C; Darbyshire JH; Emery S; Phillips A; Lundgren JD; Neaton JD, 2008, 'Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy - a randomized trial', Annals of Internal Medicine, 149, pp. 289 - W62
Wand H; Calmy A; Carey DL; Samaras K; Carr A; Law MG; Cooper DA; Emery S, 2007, 'Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection', AIDS, 21, pp. 2445 - 2453, http://dx.doi.org/10.1097/QAD.0b013e3282efad32
Arenas-Pinto A; Copas A; Weller I; Grant A; Dunn D; Bhaskaran K; Carr A; Reiss P; Edwards S; Worm SW; Overton T; Martinez E; Hoy J; Cahn P; Weber R, 2007, 'Risk factors for lactic acidosis and severe hyperlactataemia in HIV-1-infected adults exposed to antiretroviral therapy', AIDS, 21, pp. 2455 - 2464, http://dx.doi.org/10.1097/QAD.0b013e3282f08cdc
Carr A, 2007, 'Treatment strategies for HIV lipodystrophy', Current Opinion in HIV and AIDS, 2, pp. 332 - 338, http://dx.doi.org/10.1097/COH.0b013e3281df2b57
Ellis KJ; Grund B; Visnegarwala F; Thackeray L; Miller CG; Chesson CE; El-Sadr W; Carr A, 2007, 'Visceral and subcutaneous adiposity measurements in adults: Influence of measurement site', Obesity, 15, pp. 1441 - 1447, http://dx.doi.org/10.1038/oby.2007.172
Fox Z; Antunes F; Davey R; Gazzard B; Klimas N; Labriola A; Losso M; Neaton JD; Phillips A; Ruxrungtham K; Staszewski S; Weiss L; Lundgren DJ; Aguilar L; Angel EB; Aquilia S; Belloso W; Benetucci J; Bittar V; Cahn P; Casiro A; Contarelli J; Corral J; Daciuk L; David D; Ferrari I; Fridman D; Galache V; Guaragna G; Ivalo S; Laplume H; Lanusse I; Lasala MB; Lattes R; Lasovsky J; Lopardo G; Lourtau L; Lupo S; Maranzana A; Marson C; Massera L; Sanchez MDL; Somenzini C; Tocci M; Algar S; Anderson J; Baker D; Blavius K; Bloch M; Boyle M; Bradford D; Britton P; Carrall L; Carr A; Chuah J; Curry M; D'Arcy-Evans C; Dobson P; Doong N; Egan C; Ferguson W; Finlayson R; French M; Frater A; Gold J; Habel P; Haig K; Holland R; Hyland N; Hoy J; Hudson J; James R; Leung J; Lowe K; MacRae K; McMurchie M; Medland N; Miller S; Murray J; Newman R; David O; Patching J; Primrose R; Ree H; Richardson R; Rogers G; Roney J; Roth N; Sarangapany J; Shaw D; Silberberg C; Skett A; Vale R; Villella C; Walker A; Watson A; Wendt N; Wood H, 2007, 'Predictors of CD4 count change over 8 months of follow up in HIV-1-infected patients with a CD4 count ≥ 300 cells/μL who were assigned to 7.5 MIU interleukin-2', HIV Medicine, 8, pp. 112 - 123, http://dx.doi.org/10.1111/j.1468-1293.2007.00440.x
Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A, 2007, 'Erratum: Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: Associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and hypoadiponectinemia (Diabetes Care (2007) 30, (113-119))', Diabetes Care, 30, pp. 455, http://dx.doi.org/10.2337/dc07-er02
May M; Sterne JA; Shipley M; Brunner E; d Agostino R; Whincup P; Ben-Shlomo Y; Carr AD; Ledergerber B; Lundgren JD; Phillips A; Massaro J; Eggerl M, 2007, 'A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected men', International Journal of Epidemiology, 36, pp. 1309 - 1318
Boyd MA; Truman M; Hales GP; Anderson JS; Dwyer DE; Carr AD, 2007, 'A randomized study to evaluate injection site reactions (ISR) using three different mechanisms for delivery of enfuvirtide (ENF): a 27-gauge needle, a 31-gauge needle and a needle-free device', Antiviral Therapy, 12, pp. L57 - L57
Carey DL; Baker D; Rogers G; Petoumenos K; Chuah J; Easey N; Mahon K; Cooper DA; Emery S; Carr AD, 2007, 'A randomized, multicenter, open-label study of poly-l-lactic acid for HIV-1 facial lipoatrophy', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 46, pp. 581 - 589
Calmy A; Hirschel B; Cooper DA; Carr AD, 2007, 'Clinical update: adverse effects of antiretroviral therapy', Lancet, 370, pp. 12 - 14
Calmy A; Petoumenos K; Lewden C; Law M; Bocquentin F; Hesse K; Cooper D; Carr A; Bonnet F; Aquitaine Cohort, Australian HIV Observational Database and St Vincent's Hospital Cohort study groups , 2007, 'Combination antiretroviral therapy without a nucleoside reverse transcriptase inhibitor: experience from 334 patients in three cohorts.', HIV Med, 8, pp. 171 - 180, http://dx.doi.org/10.1111/j.1468-1293.2007.00448.x
Prineas R; Roediger M; Carr AD; El-Sadr W; Esser S; Grandits G; Knysz B; Palfreeman A, 2007, 'Effect of alternate treatment protocols on the incidence of electrocardiographic abnormalities among HIV-infected adults in the SMART trial', Antiviral Therapy, 12, pp. L11 - L11
Carr AD; Zajdenverg R; Workman C; Gatell J; Cahn PE; Ritzhaupt A; Zhang W; Chaves R, 2007, 'Effects of tipranavir/r (500/200 or 500/100 mg BID) in comparison with lopinavir/r (400/100 ing BID) on changes in body composition and metabolic parameters in ARV-naive patients over 48 weeks', Antiviral Therapy, 12, pp. L8 - L9
Samaras K; Wand HC; Law MG; Emery S; Cooper DA; Carr AD, 2007, 'Prevalence of Metabolic Syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria', Diabetes Care, 30, pp. 113 - 119, http://dx.doi.org/10.2337/dc06-1075
Carr A; Ory D, 2006, 'Does HIV cause cardiovascular disease?', Plos Medicine, 3, pp. 1986 - 1987, http://dx.doi.org/10.1371/journal.pmed.0030496
Boyd MA; Carr A; Ruxrungtham K; Srasuebkul P; Bien D; Law M; Wangsuphachart S; Krisanachinda A; Lerdlum S; Lange JMA; Phanuphak P; Cooper DA; Reiss P, 2006, 'Changes in body composition and mitochondrial nucleic acid content in patients switched from failed nucleoside analogue therapy to ritonavir-boosted indinavir and efavirenz', Journal of Infectious Diseases, 194, pp. 642 - 650, http://dx.doi.org/10.1086/505709
Collins S; Mertenskoetter T; Loeliger E; Tressler R; Weller I; Friis-Møller N; Worm SW; Sabin CA; Sjøl A; Lundgren JD; Sawitz A; Rickenbach M; Pezzotti P; Krum E; Gras L; Balestre E; Sundström A; Poll B; Fontas E; Torres F; Petoumenos K; Kjær J; Weber R; Reisswafaamel-Sadr P; Kirk O; Dabis F; Law MG; Pradier C; De Wit S; Akerlund B; Calvo G; Monforte ADA; Ledergerber B; Phillips AN; De Wolf F; Zaheri S; Bronsveld W; Hillebrand-Haverkort ME; Prins JM; Bos JC; Schattenkerk JKME; Geerlings SE; Godfried MH; Lange JMA; Van Leth FC; Lowe SH; Van Der Meer JTM; Nellen FJB; Pogány K; Van Der Poll T; Reiss P; Ruys TA; Sankatsing SU; Steingrover R; Van Twillert G; Van Der Valk M; Van Vonderen MGA; Vrouenraets SME; Van Vugt MV; Wit FWMN; Van Eeden A; Ten Veen JH; Van Dam PS; Roos JC; Brinkman K; Frissen PHJ; Weigel HM; Mulder JW; Van Gorp ECM; Meenhorst PL; Mairuhu ATA; Veenstra J; Danner SA; Van Agtmael MA; Claessen FAP; Perenboom RM; Rijkeboer A; Richter C; Van Der Berg J; Van Leusen R; Vriesendorp R; Jeurissen FJF; Kauffmann RH; Koger ELW; Bravenboer B; Ten Napel CHH; Kootstra GJ; Sprenger HG; Miesen WMAJ; Doedens R; Scholvinck EH; Ten Kate RW; Van Houte DPF; Polee M; Kroon FP; Van Den Broek PJ; Van Dissel JT; Schippers EF; Schreij G; Van De Geest S, 2006, 'Liver-related deaths in persons infected with the human immunodeficiency virus: The D:A:D Study', Archives of Internal Medicine, 166, pp. 1632 - 1641, http://dx.doi.org/10.1001/archinte.166.15.1632
Pett SL; Wand H; Law MG; Arduino R; Lopez JC; Knysz B; Pereira LC; Pollack S; Reiss P; Tambussi G; Abrams DI; Cooper DA; Darbyshire JH; Duncan WR; Emery S; Clifford Lane H; Lehrman S; Lundgren JD; Neaton JD; Aguilar L; Angel EB; Aquilia S; Belloso W; Benetucci J; Bittar V; Cahn P; Casiro A; Contarelli J; Corral J; Daciuk L; David D; Ines F; Fridman D; Galache V; Guaragna G; Ivalo S; Laplume H; Lasala MB; Lattes R; Lasovsky J; Lopardo G; Losso M; Lourtau L; Lupo S; Maranzana A; Marson C; Massera L; del Lujan Sanchez M; Somenzini C; Tocci M; Algar S; Anderson J; Austin D; Baker D; Blavius K; Bloch M; Boyle M; Bradford D; Carrall L; Carr A; Chuah J; Curry M; D'Arcy-Evans C; Dobson P; Doong N; Ferguson W; Finlayson R; French M; Gold J; Habel P; Hoy J; Hudson J; James R; Jeganathan S; Leung J; Lowe K; MacRae K; Mallal S; McMurchie M; Medland N; Mijch A; Miller S; Murray J; Orth D; Patching J; Primrose R; Quan D; Rawlinson M; Ree H; Richardson R; Rogers G; Roney J; Roth N; Shaw D; Soo TM; Sowden D; Street A; Street A; Vale R, 2006, 'Evaluation of subcutaneous proleukin (interleukin-2) in a randomized international trial (ESPRIT): Geographical and gender differences in the baseline characteristics of participants', HIV Clinical Trials, 7, pp. 70 - 85, http://dx.doi.org/10.1310/4733-ACQF-F3P4-2QAC
Samaras K; Wand HC; Law MG; Emery S; Cooper DA; Carr AD, 2006, 'Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition and metabolic parameters', Antiviral Therapy, 11, pp. L23 - L24
Calmy A; Carey DL; Mallon PW; Wand HC; Cooper DA; Law MG; Carr AD, 2006, 'Early changes in adiponectin and leptin levels predict changes in limb fat mass over 2 years following initiation of antiretroviral therapy', Antiviral Therapy, 11, pp. L12 - L12
Mallon PW; Miller JE; Kovacic JC; Kent-Hughes J; Norris RP; Samaras K; Feneley MP; Cooper DA; Carr AD, 2006, 'Effect of pravastatin on body composition and markers of cardiovascular disease in HIV-infected men - a randomized, placebo-controlled study', AIDS, 20, pp. 1003 - 1010
Law MG; Puls R; Cheng A; Cooper DA; Carr AD, 2006, 'Evaluation of the HIV lipodystrophy case definition in a placebo-controlled, 144-week study in antiretroviral-naive adults', Antiviral Therapy, 11, pp. 179 - 186
Carr AD, 2006, 'Investigating new antiretroviral combinations', Journal of Infectious Diseases, 193, pp. 1742 - 1742
Hamlyn E; McAllister J; Winston A; Sinclair B; Amin J; Carr AD; Cooper DA, 2006, 'Is screening for sexually transmitted infections in men who have sex with men who receive non-occupational HIV post-exposure prophylaxis worthwhile?', Sexually Transmitted Infections, 82, pp. 21 - 23
Back to profile page